Guangzhou Improve Med Instrument (300030) — Working Capital to Net Assets Ratio
Guangzhou Improve Med Instrument (300030) has a Working Capital to Net Assets ratio of 19.9% as of March 2026. Working capital of CN¥134.60 Million (current assets of CN¥430.17 Million minus current liabilities of CN¥295.56 Million) is measured against net assets of CN¥677.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Guangzhou Improve Med Instrument defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangzhou Improve Med Instrument Working Capital to Net Assets (2006–2025)
This chart shows how Guangzhou Improve Med Instrument's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 19.9%, reflecting working capital of CN¥134.60 Million against net assets of CN¥677.10 Million CNY. For the complete balance sheet picture, see Guangzhou Improve Med Instrument balance sheet assets.
Annual Working Capital to Net Assets for Guangzhou Improve Med Instrument (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangzhou Improve Med Instrument from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Guangzhou Improve Med Instrument to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.1% | CN¥105.47 Million | CN¥655.10 Million | CN¥423.34 Million | CN¥317.87 Million | ▲ +4.1 pp |
| 2024 | 12.0% | CN¥77.03 Million | CN¥643.86 Million | CN¥589.10 Million | CN¥512.07 Million | ▲ +4.0 pp |
| 2023 | 8.0% | CN¥61.06 Million | CN¥762.33 Million | CN¥664.43 Million | CN¥603.37 Million | ▼ -1.7 pp |
| 2022 | 9.7% | CN¥79.78 Million | CN¥820.61 Million | CN¥718.24 Million | CN¥638.46 Million | ▼ -6.4 pp |
| 2021 | 16.1% | CN¥166.30 Million | CN¥1.03 Billion | CN¥843.94 Million | CN¥677.64 Million | ▼ -23.3 pp |
| 2020 | 39.4% | CN¥395.41 Million | CN¥1.00 Billion | CN¥860.05 Million | CN¥464.63 Million | ▲ +24.1 pp |
| 2019 | 15.3% | CN¥128.21 Million | CN¥838.26 Million | CN¥702.19 Million | CN¥573.98 Million | ▼ -34.2 pp |
| 2018 | 49.5% | CN¥403.65 Million | CN¥815.47 Million | CN¥715.88 Million | CN¥312.22 Million | ▲ +2.1 pp |
| 2017 | 47.4% | CN¥456.54 Million | CN¥963.72 Million | CN¥749.37 Million | CN¥292.83 Million | ▲ +28.2 pp |
| 2016 | 19.2% | CN¥183.33 Million | CN¥954.18 Million | CN¥596.05 Million | CN¥412.73 Million | ▼ -5.6 pp |
| 2015 | 24.8% | CN¥230.66 Million | CN¥930.46 Million | CN¥603.78 Million | CN¥373.12 Million | ▼ -8.4 pp |
| 2014 | 33.2% | CN¥259.44 Million | CN¥782.00 Million | CN¥450.38 Million | CN¥190.94 Million | ▼ -25.8 pp |
| 2013 | 59.0% | CN¥455.72 Million | CN¥772.70 Million | CN¥537.79 Million | CN¥82.07 Million | ▲ +0.7 pp |
| 2012 | 58.3% | CN¥400.80 Million | CN¥687.93 Million | CN¥467.15 Million | CN¥66.35 Million | ▼ -4.8 pp |
| 2011 | 63.1% | CN¥408.88 Million | CN¥648.25 Million | CN¥468.90 Million | CN¥60.02 Million | ▼ -11.6 pp |
| 2010 | 74.7% | CN¥442.46 Million | CN¥592.55 Million | CN¥495.37 Million | CN¥52.91 Million | ▼ -9.6 pp |
| 2009 | 84.2% | CN¥474.75 Million | CN¥563.53 Million | CN¥547.20 Million | CN¥72.45 Million | ▲ +38.4 pp |
| 2008 | 45.8% | CN¥36.06 Million | CN¥78.73 Million | CN¥79.98 Million | CN¥43.92 Million | ▼ -21.8 pp |
| 2007 | 67.6% | CN¥39.38 Million | CN¥58.27 Million | CN¥53.95 Million | CN¥14.56 Million | ▲ +21.8 pp |
| 2006 | 45.8% | CN¥8.84 Million | CN¥19.33 Million | CN¥28.07 Million | CN¥19.22 Million | — |